Back to top

Clearmind reports positive retention results for intranasal formulation of MEAI

Clearmind Medicine (CMND) announced “compelling” ex vivo mucoadhesion results for its intranasal formulation of MEAI. “Leveraging a nasal drug-deli...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: